Literature DB >> 14770271

Translational research using the sodium/iodide symporter in imaging and therapy.

June-Key Chung, Joo Hyun Kang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14770271     DOI： 10.1007/s00259-004-1475-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

1.  Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo.

Authors:  M Doubrovin; V Ponomarev; T Beresten; J Balatoni; W Bornmann; R Finn; J Humm; S Larson; M Sadelain; R Blasberg; J Gelovani Tjuvajev
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

2.  Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.

Authors:  C Spitzweg; M K O'Connor; E R Bergert; D J Tindall; C Y Young; J C Morris
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

3.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography.

Authors:  S S Gambhir; J R Barrio; M E Phelps; M Iyer; M Namavari; N Satyamurthy; L Wu; L A Green; E Bauer; D C MacLaren; K Nguyen; A J Berk; S R Cherry; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.

Authors:  U Haberkorn; M Henze; A Altmann; S Jiang; I Morr; M Mahmut; P Peschke; W Kübler; J Debus; M Eisenhut
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

5.  Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.

Authors:  A Boland; M Ricard; P Opolon; J M Bidart; P Yeh; S Filetti; M Schlumberger; M Perricaudet
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

6.  Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.

Authors:  J J Min; J K Chung; Y J Lee; J M Jeong; D S Lee; J J Jang; M C Lee; B Y Cho
Journal:  Eur J Nucl Med       Date:  2001-05

7.  Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.

Authors:  Jae Hoon Shin; June-Key Chung; Joo Hyun Kang; Yong Jin Lee; Kwang Il Kim; Chul Woo Kim; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

8.  In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.

Authors:  J-Y Cho; D H Y Shen; W Yang; B Williams; T L F Buckwalter; K M D La Perle; G Hinkle; R Pozderac; R Kloos; H N Nagaraja; R F Barth; S M Jhiang
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

9.  Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.

Authors:  R B Mandell; L Z Mandell; C J Link
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

10.  Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.

Authors:  B Caillou; F Troalen; E Baudin; M Talbot; S Filetti; M Schlumberger; J M Bidart
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958
View more
  8 in total

1.  From the magic bullet to an effective therapy: the peptide experience.

Authors:  Luigi Mansi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

2.  A new PET probe, (18)F-tetrafluoroborate, for the sodium/iodide symporter: possible impacts on nuclear medicine.

Authors:  Hyewon Youn; Jae Min Jeong; June-Key Chung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-07       Impact factor: 9.236

Review 3.  Gene expression and gene therapy imaging.

Authors:  Claire Rome; Franck Couillaud; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2006-09-12       Impact factor: 5.315

Review 4.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 5.  Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.

Authors:  June-Key Chung; Hye Won Youn; Joo Hyun Kang; Ho Young Lee; Keon Wook Kang
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

Review 6.  The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies.

Authors:  Alan R Penheiter; Stephen J Russell; Stephanie K Carlson
Journal:  Curr Gene Ther       Date:  2012-02-01       Impact factor: 4.391

7.  Expression patterns of glucose transporter-1 gene and thyroid specific genes in human papillary thyroid carcinoma.

Authors:  Sungeun Kim; June-Key Chung; Hae-Sook Min; Joo-Hyun Kang; Do Joon Park; Jae Min Jeong; Dong Soo Lee; Sung-Hwae Park; Bo Youn Cho; Sinae Lee; Myung Chul Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-01-25

8.  Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.

Authors:  Young-Hwa Kim; Hyewon Youn; Juri Na; Kee-Jong Hong; Keon Wook Kang; Dong Soo Lee; June-Key Chung
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.